Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver

• Published in: Psychopharmacologia 2009-03, Vol.203 (1), p.73-84
• Main Authors: Fernø, Johan, Vik-Mo, Audun O., Jassim, Goran, Håvik, Bjarte, Berge, Kjetil, Skrede, Silje, Gudbrandsen, Oddrun A., Waage, Jo, Lunder, Niclas, Mørk, Sverre, Berge, Rolf K., Jørgensen, Hugo A., Steen, Vidar M.
• Format: Article
• Language: English
• Subjects: Animals; Antipsychotic Agents - administration & dosage; Antipsychotic Agents - toxicity; Biological and medical sciences; Biomedical and Life Sciences; Biomedicine; Cholesterol Esters - metabolism; Clozapine - administration & dosage; Clozapine - toxicity; DNA-Binding Proteins - metabolism; Female; Gene expression; Gene Expression Regulation - drug effects; Injections, Intraperitoneal; Lipase - genetics; Lipid Metabolism - drug effects; Lipid Metabolism - genetics; Lipids; Liver; Liver - drug effects; Liver - enzymology; Liver - metabolism; Liver X Receptors; Male; Medical sciences; Neuropharmacology; Neurosciences; Original Investigation; Orphan Nuclear Receptors; Pharmacology. Drug treatments; Pharmacology/Toxicology; Phospholipids - metabolism; PPAR alpha - metabolism; Psychiatry; Psycholeptics: tranquillizer, neuroleptic; Psychology. Psychoanalysis. Psychiatry; Psychopharmacology; Psychotropic drugs; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear - metabolism; Rodents; Sterol Regulatory Element Binding Protein 1 - metabolism; Time Factors; Triglycerides - metabolism
• ISSN: 0033-3158; 1432-2072
• DOI: 10.1007/s00213-008-1370-x

Background Several antipsychotic drugs (APDs) have high propensity to induce weight gain and dyslipidemia in patients, with clozapine and olanzapine as the most potent drugs. These lipid-related effects have been attributed to drug-mediated blockade or antagonism of histamine H1 and serotonin 5-HT2 receptors as well as activation of hypothalamic AMP-activated protein kinase. We recently showed that APDs activate lipid biosynthesis in cultured liver cells through stimulation of the sterol regulatory element-binding protein (SREBP) transcription factors. Objective The objective of the study was to search for clozapine-related lipogenic effects in peripheral tissues in vivo using rat liver as target organ. Materials and methods Adult female Sprague–Dawley rats were administered single intraperitoneal injections of clozapine (25 and 50 mg/kg). Hepatic lipid levels were measured during a 48-h time course. Real-time quantitative PCR was used to analyze expression of genes involved in lipid biosynthesis, oxidation, efflux, and lipolysis. Results We identified an initial up-regulation of central lipogenic SREBP target genes, followed by a marked and sustained down-regulation. We also observed a sequential transcriptional response for fatty acid β-oxidation and cholesterol efflux genes, normally controlled by the peroxisome proliferator activated receptor alpha and liver X receptor alpha transcription factors, and also down-regulation of genes encoding major lipases. The transcriptional responses were associated with a significant accumulation of triacylglycerol, phospholipids, and cholesterol in the liver. Conclusion These results demonstrate that acute clozapine exposure affects SREBP-regulated lipid biosynthesis as well as other lipid homeostasis pathways. We suggest that such drug-induced effects on lipid metabolism in peripheral tissues are relevant for the metabolic adverse effects associated with clozapine and possibly other APDs.